Nature Communications (May 2017)

TGF-β activation by bone marrow-derived thrombospondin-1 causes Schistosoma- and hypoxia-induced pulmonary hypertension

  • Rahul Kumar,
  • Claudia Mickael,
  • Biruk Kassa,
  • Liya Gebreab,
  • Jeffrey C. Robinson,
  • Daniel E. Koyanagi,
  • Linda Sanders,
  • Lea Barthel,
  • Christina Meadows,
  • Daniel Fox,
  • David Irwin,
  • Min Li,
  • B. Alexandre McKeon,
  • Suzette Riddle,
  • R. Dale Brown,
  • Leslie E. Morgan,
  • Christopher M. Evans,
  • Daniel Hernandez-Saavedra,
  • Angela Bandeira,
  • James P. Maloney,
  • Todd M. Bull,
  • William J. Janssen,
  • Kurt R. Stenmark,
  • Rubin M. Tuder,
  • Brian B. Graham

DOI
https://doi.org/10.1038/ncomms15494
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 13

Abstract

Read online

Thrombospondin-1 (TSP-1) activates latent TGF-β in the extracellular matrix. Here the authors show that inappropriate activation of latent TGF-β in murine, bovine and human lung by monocyte-produced TSP-1 causes pulmonary hypertension, and that interference with the activation process prevents disease development.